🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 05360L304 (prev. 05360L106 )
- Market Cap
- Micro Cap
- IPO
- 6/27/2017 · $6.00/share
- Parent Company
- Fortress Biotech, Inc. (FBIO)
Business: Avenue Therapeutics, Inc. is a New York-based, specialty pharmaceutical company focused on the development and commercialization of an intravenous formulation of tramadol HCl for the management of moderate to moderately severe postoperative pain.
Company Contact
- CEO
- Alexandra MacLean
- CFO
- David Jin
- Headquarters
- 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154
- Phone
- 781-652-4500
- Investor Relations
- Jaclyn Jaffe · 781-652-4500 · ir@avenuetx.com